Good, Bad, and Ugly

The wrong co-founder

ballmer.jpgIn your video regarding Bill Gates leaving Microsoft and how Steve Ballmer will become the leader at Microsoft, you incorrectly stated that Steve Ballmer co-founded Microsoft.

The round-up

Sprint prices iPhone rival Instinct at $130

iphone-200.jpgNEW YORK (Reuters) – The Instinct, Sprint Nextel Corp’s answer to the iPhone, will sell for $130 after rebate, Sprint said on Wednesday.

Best choice for economy?

McCain seen as best choice for economy

mccain-180.jpgNEW YORK (Reuters) – Republican presidential candidate John McCain’s tax policies have given him an edge as the better man for the economy, various Wall Street experts said at this week’s Reuters Investment Outlook Summit.

The price of oil

Before the Bell: All About Lehman

oil-180.jpgOil prices have rebounded somewhat, with U.S. crude above $135 a gallon, after a sharp fall in response to news that Saudi Arabia is pushing output to its highest level in decades.

Another bad currency conversion

Serb thief buries 83.5 mln pounds in park

BELGRADE (Reuters) – A Serbian bank clerk who stole nearly 1.5 million euros (83.5 million pounds) from his bank left a note reading “I’m sorry”, buried the loot in a park and waited at a cafe for police to arrest him.

Gross Domestic Product

Exxon profit disappoints despite high oil prices  

exxon-180.jpgExxon posted record earnings of $40.6 billion in 2007, with revenue higher than the gross domestic profit of Turkey, the world’s 17th-largest economy.

The wrong time frame

Medtronic unit agrees to consent decree with FDA

In September, Medtronic announced plans to eliminate about 200 jobs in the Physio-Control unit.

Who acquired whom?

AT&T to axe about 4,600 jobs, take charge

AT&T, which posted a 2007 fourth-quarter profit of $3.1 billion, has made several acquisitions in recent years, including SBC Communications and BellSouth.

Plowing ahead…

Schering, Merck Cholesterol Prescriptions Slide

schering-200.gifNEW YORK (Reuters) – U.S. prescriptions of Schering-Plow Corp’s cholesterol drugs fell 13 percent in February from a month earlier, following results of a controversial study, the drug maker said on Tuesday.